Agency Information Collection Activities; Proposed Collection; Comment Request; Manufactured Food Regulatory Program Standards, 2162-2163 [2022-00559]
Download as PDF
2162
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
Based on a review of the information
collection since our last request for
OMB approval, we have made no
adjustments to our burden estimate.
Dated: January 4, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–00561 Filed 1–12–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0414]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Manufactured
Food Regulatory Program Standards
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection provisions of the
Manufactured Food Regulatory Program
Standards.
DATES: Submit either electronic or
written comments on the collection of
information by March 14, 2022.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before March 14,
2022. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of March 14, 2022. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
jspears on DSK121TN23PROD with NOTICES1
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
VerDate Sep<11>2014
19:23 Jan 12, 2022
Jkt 256001
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2010–N–0414 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request;
Manufactured Food Regulatory Program
Standards.’’ Received comments, those
filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Rachel Showalter, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 240–994–7399, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3521), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
E:\FR\FM\13JAN1.SGM
13JAN1
2163
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Manufactured Food Regulatory
Program Standards
OMB Control Number 0910–0601—
Extension
This information collection supports
FDA’s ‘‘Manufactured Food Regulatory
Program Standards’’ (2019) (https://
www.fda.gov/media/131392/download).
We recommend that States use these
program standards as the framework to
design and manage their manufactured
food programs. There are 44 State
programs currently enrolled in the
Manufactured Food Regulatory Program
Standards (MFRPS) under cooperative
agreements.
The goal of the MFRPS is to
implement a nationally integrated, riskbased, food safety system focused on
protecting public health. The MFRPS
establish a uniform basis for measuring
and improving the performance of
prevention, intervention, and response
activities of manufactured food
regulatory programs in the United
States. The development and
implementation of the standards will
help Federal and State programs better
direct their regulatory activities toward
reducing foodborne illness. For more
information we invite you to visit our
website at: https://www.fda.gov/federalstate-local-tribal-and-territorialofficials/regulatory-program-standards/
manufactured-food-regulatory-programstandards-mfrps.
FDA recommends that a State
program enrolled in the MFRPS use the
worksheets and forms contained in the
standards; however, alternate forms that
are equivalent may be used. The State
program maintains documentation
(guidance, procedures, documents, and
forms) required by the 10 standards,
which must be current and fit for use.
In the first year of implementing the
program standards, the State program
conducts a baseline self-assessment of
the documentation to determine if it
meets the elements of each standard.
The State program must participate in
additional verification audits in
subsequent years. After 5 years, FDA
will conduct a comprehensive program
audit of the documentation. As part of
the program audit, the auditor reviews
the records and supporting documents
required by the criteria in each standard
to determine if the self-assessment and
improvement plan accurately reflect the
State program’s level of conformance
with each of the standards. If the State
program fails to meet all program
elements and documentation
requirements of a standard, it develops
a strategic plan which includes the
following: (1) The individual element of
documentation requirement of the
standard that was not met, (2)
improvements needed to meet the
program element or documentation
requirement of the standard, and (3)
projected completion dates for each
task.
Description of Respondents:
Respondents are State Departments of
Agriculture or Health enrolled in the
MFRPS (State Governments).
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Type of respondent; activity
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
Total hours
State Governments; Development and reporting of data
consistent with MFRPS ....................................................
44
1
44
569
25,036
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Type of respondent; activity
Number of
recordkeepers
Number of
records per
recordkeeper
Total annual
records
Average
burden per
recordkeeping
Total hours
State Governments; Maintenance of data records consistent with MFRPS ..........................................................
44
10
440
40
17,600
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
jspears on DSK121TN23PROD with NOTICES1
We have adjusted the number of
respondents to the information
collection to reflect the enrollment of an
additional State since our last
evaluation.
Dated: January 6, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–00559 Filed 1–12–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2021–N–0973]
Revocation of Three Authorizations of
Emergency Use of In Vitro Diagnostic
Devices for Detection and/or Diagnosis
of COVID–19; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
VerDate Sep<11>2014
18:18 Jan 12, 2022
Jkt 256001
PO 00000
Notice.
Frm 00038
Fmt 4703
Sfmt 4703
The Food and Drug
Administration (FDA) is announcing the
revocation of the Emergency Use
Authorizations (EUAs) (the
Authorizations) issued to Becton,
Dickinson & Company (BD) for the
BioGX SARS–CoV–2 Reagents for BD
MAX System, Boston Medical Center for
the BMC–CReM COVID–19 Test, and
Akron Children’s Hospital for the Akron
Children’s Hospital SARS–CoV–2
Assay. FDA revoked these
Authorizations on December 8, 2021,
under the Federal Food, Drug, and
SUMMARY:
E:\FR\FM\13JAN1.SGM
13JAN1
Agencies
[Federal Register Volume 87, Number 9 (Thursday, January 13, 2022)]
[Notices]
[Pages 2162-2163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0414]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Manufactured Food Regulatory Program Standards
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the information collection provisions of
the Manufactured Food Regulatory Program Standards.
DATES: Submit either electronic or written comments on the collection
of information by March 14, 2022.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before March 14, 2022. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of March 14, 2022. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2010-N-0414 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Manufactured Food Regulatory
Program Standards.'' Received comments, those filed in a timely manner
(see ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: Rachel Showalter, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 240-994-7399,
[email protected].
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites
[[Page 2163]]
comments on these topics: (1) Whether the proposed collection of
information is necessary for the proper performance of FDA's functions,
including whether the information will have practical utility; (2) the
accuracy of FDA's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques, when appropriate, and other forms of
information technology.
Manufactured Food Regulatory Program Standards
OMB Control Number 0910-0601--Extension
This information collection supports FDA's ``Manufactured Food
Regulatory Program Standards'' (2019) (https://www.fda.gov/media/131392/download). We recommend that States use these program standards
as the framework to design and manage their manufactured food programs.
There are 44 State programs currently enrolled in the Manufactured Food
Regulatory Program Standards (MFRPS) under cooperative agreements.
The goal of the MFRPS is to implement a nationally integrated,
risk-based, food safety system focused on protecting public health. The
MFRPS establish a uniform basis for measuring and improving the
performance of prevention, intervention, and response activities of
manufactured food regulatory programs in the United States. The
development and implementation of the standards will help Federal and
State programs better direct their regulatory activities toward
reducing foodborne illness. For more information we invite you to visit
our website at: https://www.fda.gov/federal-state-local-tribal-and-territorial-officials/regulatory-program-standards/manufactured-food-regulatory-program-standards-mfrps.
FDA recommends that a State program enrolled in the MFRPS use the
worksheets and forms contained in the standards; however, alternate
forms that are equivalent may be used. The State program maintains
documentation (guidance, procedures, documents, and forms) required by
the 10 standards, which must be current and fit for use. In the first
year of implementing the program standards, the State program conducts
a baseline self-assessment of the documentation to determine if it
meets the elements of each standard. The State program must participate
in additional verification audits in subsequent years. After 5 years,
FDA will conduct a comprehensive program audit of the documentation. As
part of the program audit, the auditor reviews the records and
supporting documents required by the criteria in each standard to
determine if the self-assessment and improvement plan accurately
reflect the State program's level of conformance with each of the
standards. If the State program fails to meet all program elements and
documentation requirements of a standard, it develops a strategic plan
which includes the following: (1) The individual element of
documentation requirement of the standard that was not met, (2)
improvements needed to meet the program element or documentation
requirement of the standard, and (3) projected completion dates for
each task.
Description of Respondents: Respondents are State Departments of
Agriculture or Health enrolled in the MFRPS (State Governments).
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Type of respondent; activity Number of responses per Total annual Average burden Total hours
respondents respondent responses per response
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Governments; Development and reporting of data consistent 44 1 44 569 25,036
with MFRPS........................................................
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 2--Estimated Annual Recordkeeping Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent; activity Number of records per Total annual per Total hours
recordkeepers recordkeeper records recordkeeping
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Governments; Maintenance of data records consistent with 44 10 440 40 17,600
MFRPS.............................................................
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
We have adjusted the number of respondents to the information
collection to reflect the enrollment of an additional State since our
last evaluation.
Dated: January 6, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-00559 Filed 1-12-22; 8:45 am]
BILLING CODE 4164-01-P